{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T18:11:26Z","timestamp":1793211086166,"version":"4.5.0"},"reference-count":57,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,3,16]],"date-time":"2026-03-16T00:00:00Z","timestamp":1773619200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Oncol."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Hepatocellular carcinoma (HCC) recurrence after curative resection remains a critical challenge that significantly compromises long-term survival. This study aimed to develop a novel blood-based prognostic scoring system integrating circulating tumor cells (CTCs) and aspartate aminotransferase-to-lymphocyte ratio index (ALRI) for predicting postoperative HCC recurrence.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      This retrospective study enrolled 160 HCC patients undergoing curative resection between January 2019 and July 2023. CTCs were detected using the Cyttel method with immunomagnetic bead negative enrichment combined with immunofluorescence\n                      <jats:italic>in situ<\/jats:italic>\n                      hybridization. COX regression identified independent factors for recurrence-free survival (RFS). Patients were stratified into three groups (CTC-ALRI scores 0, 1, 2) based on preoperative CTC status and ALRI levels. Prognostic performance was evaluated using Kaplan-Meier analysis, Cox regression, logistic regression, receiver operating characteristic curves and time-independent C-index.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Multivariate Cox regression identified baseline ALRI and CTC as independent predictors of RFS and were used to develop the CTC-ALRI score. Recurrence rates increased progressively across score groups: 24.00% (score 0), 52.11% (score 1), and 84.38% (score 2) (P&amp;lt;0.001). Median RFS exhibited a stepwise decrease corresponding to increasing CTC-ALRI scores: not reached in the score 0 group, 39.2 months in the score 1 group, and 9.2 months in the score 2 group (log-rank P&amp;lt;0.001). Both Cox regression and logistic regression analyses confirmed the CTC-ALRI score as an independent predictor of RFS and HCC recurrence. The CTC-ALRI score demonstrated excellent predictive performance for both intrahepatic and extrahepatic recurrence, as well as for early and late recurrence. Furthermore, the CTC-ALRI score outperformed conventional factors (AFP, tumor size) and established models (BCLC, TNM, ERASL, SSCLIP, Korean), with areas under the curve of 0.725 and 0.729 for one- and two-year recurrence prediction. Higher scores correlated significantly with Ki-67 proliferation index (P&amp;lt;0.05), providing biological validation.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>The preoperative CTC-ALRI score provides superior predictive accuracy for HCC recurrence following curative resection. This accessible, cost-effective biomarker enables refined risk stratification and may guide personalized surveillance and adjuvant treatment strategies.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fonc.2026.1788776","type":"journal-article","created":{"date-parts":[[2026,3,16]],"date-time":"2026-03-16T05:22:48Z","timestamp":1773638568000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":1,"title":["A blood-biomarker based CTC-ALRI score predicts recurrence in hepatocellular carcinoma patients following curative resection"],"prefix":"10.3389","volume":"16","author":[{"given":"Jinfeng","family":"Wang","sequence":"first","affiliation":[{"name":"Department of Gastroenterology, the Fourth Hospital of Hebei Medical University","place":["Shijiazhuang, Hebei, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guangjie","family":"Han","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, the Fourth Hospital of Hebei Medical University","place":["Shijiazhuang, Hebei, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Han","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, the Fourth Hospital of Hebei Medical University","place":["Shijiazhuang, Hebei, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianfei","family":"Shi","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, the Fourth Hospital of Hebei Medical University","place":["Shijiazhuang, Hebei, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lili","family":"Mi","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, the Fourth Hospital of Hebei Medical University","place":["Shijiazhuang, Hebei, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ning","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, the Fourth Hospital of Hebei Medical University","place":["Shijiazhuang, Hebei, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Man","family":"Zhao","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, the Fourth Hospital of Hebei Medical University","place":["Shijiazhuang, Hebei, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoling","family":"Duan","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, the Fourth Hospital of Hebei Medical University","place":["Shijiazhuang, Hebei, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fei","family":"Yin","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, the Fourth Hospital of Hebei Medical University","place":["Shijiazhuang, Hebei, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,3,16]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21834","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J Clin"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2024.08.028","article-title":"EASL Clinical Practice Guidelines on the management of hepatocellular carcinoma","volume":"82","year":"2025","journal-title":"J Hepatol"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdy308","article-title":"Hepatocellular carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up","volume":"29","author":"Vogel","year":"2018","journal-title":"Ann Oncol Off J Eur Soc Med Oncol"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1016\/s0168-8278(02)00360-4","article-title":"Risk factors contributing to early and late phase intrahepatic recurrence of hepatocellular carcinoma after hepatectomy","volume":"38","author":"Imamura","year":"2003","journal-title":"J Hepatol"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMe0807581","article-title":"Recurrence of hepatocellular carcinoma","volume":"359","author":"Sherman","year":"2008","journal-title":"N Engl J Med"},{"key":"B6","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1038\/s41392-021-00838-3","article-title":"Whole-genome sequencing reveals the evolutionary trajectory of HBV-related hepatocellular carcinoma early recurrence","volume":"7","author":"Zhou","year":"2022","journal-title":"Signal Transd Targ Ther"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1111\/hpb.12367","article-title":"Risk factors and management for early and late intrahepatic recurrence of solitary hepatocellular carcinoma after curative resection","volume":"17","author":"Cheng","year":"2015","journal-title":"HPB"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v29.i8.1243","article-title":"Predictors of early and late hepatocellular carcinoma recurrence","volume":"29","author":"Nevola","year":"2023","journal-title":"World J Gastroenterol"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1016\/j.acra.2023.09.008","article-title":"Radiomics-based machine learning to predict the recurrence of hepatocellular carcinoma: A systematic review and meta-analysis","volume":"31","author":"Jin","year":"2024","journal-title":"Acad Radiol"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-025-08668-x","article-title":"Spatial immune scoring system predicts hepatocellular carcinoma recurrence","volume":"640","author":"Jia","year":"2025","journal-title":"Nature"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2022-328428","article-title":"Distinct single-cell immune ecosystems distinguish true and de novo HBV-related hepatocellular carcinoma recurrences","volume":"72","author":"Chen","year":"2023","journal-title":"Gut"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2024.1446386","article-title":"Deep learning radiomics based on contrast enhanced MRI for preoperatively predicting early recurrence in hepatocellular carcinoma after curative resection","volume":"14","author":"Zhao","year":"2024","journal-title":"Front Oncol"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.3390\/ph16050644","article-title":"Lactylation-related gene signature effectively predicts prognosis and treatment responsiveness in hepatocellular carcinoma","volume":"16","author":"Cheng","year":"2023","journal-title":"Pharmaceuticals"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2018.05.053","article-title":"Repeatability and reproducibility of radiomic features: A systematic review","volume":"102","author":"Traverso","year":"2018","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1200\/PO.18.00074","article-title":"Estimated cost of anticancer therapy directed by comprehensive genomic profiling in a single-center study","volume":"2","author":"Chawla","year":"2018","journal-title":"JCO Precis Oncol"},{"key":"B16","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1038\/s41698-025-00858-0","article-title":"A nationwide comprehensive genomic profiling and molecular tumor board platform for patients with advanced cancer","volume":"9","author":"Volders","year":"2025","journal-title":"NPJ Precis Oncol"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1002\/cam4.5946","article-title":"Tumor-derived proliferative CTCs and CTC clusters predict aggressiveness and early recurrence in hepatocellular carcinoma patients","volume":"12","author":"Zhao","year":"2023","journal-title":"Cancer Med"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1007\/s11605-017-3619-3","article-title":"Correlation between postoperative early recurrence of hepatocellular carcinoma and mesenchymal circulating tumor cells in peripheral blood","volume":"22","author":"Wang","year":"2018","journal-title":"J Gastroint Surg Off J Soc Surg Aliment Tract"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.3390\/cancers14092081","article-title":"The significance of systemic inflammation markers in intrahepatic recurrence of early-stage hepatocellular carcinoma after curative treatment","volume":"14","author":"Bk","year":"2022","journal-title":"Cancers"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.2147\/JIR.S521603","article-title":"Pan-immune-inflammation value as a prognostic biomarker for hepatocellular carcinoma patients undergoing hepatectomy","volume":"18","author":"Fu","year":"2025","journal-title":"J Inflammation Res"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1111\/ajco.13458","article-title":"The prognostic value of aspartate aminotransferase-to-lymphocyte ratio index in early-stage hepatocellular carcinoma after hepatectomy: A propensity-score matched analysis","volume":"17","author":"Chen","year":"2021","journal-title":"Asia Pac J Clin Oncol"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.4265","article-title":"Elevated preoperative aspartate aminotransferase to lymphocyte ratio index as an independent prognostic factor for patients with hepatocellular carcinoma after hepatic resection","volume":"6","author":"Jin","year":"2015","journal-title":"Oncotarget"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1155\/2022\/3533714","article-title":"Prognostic and clinical significance of aspartate aminotransferase-to-lymphocyte ratio index in individuals with liver cancer: A meta-analysis","volume":"2022","author":"Peng","year":"2022","journal-title":"Dis Markers"},{"key":"B24","doi-asserted-by":"publisher","first-page":"1150","DOI":"10.1186\/s12885-023-11629-0","article-title":"Prognostic potential of preoperative circulating tumor cells to predict the early progression recurrence in hepatocellular carcinoma patients after hepatectomy","volume":"23","author":"Lu","year":"2023","journal-title":"BMC Cancer"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.3390\/jcm8101676","article-title":"Predictive effects of inflammatory scores in patients with BCLC 0-A hepatocellular carcinoma after hepatectomy","volume":"8","author":"Huang","year":"2019","journal-title":"J Clin Med"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.3390\/cancers16091618","article-title":"A Multicenter International Retrospective Investigation Assessing the Prognostic Role of Inflammation-Based Scores (Neutrophil-to-Lymphocyte, Lymphocyte-to-Monocyte, and Platelet-to-Lymphocyte Ratios) in Patients with Intermediate-Stage Hepatocellular Carcinoma (HCC) Undergoing Chemoembolizations of the Liver","volume":"16","author":"Minici","year":"2024","journal-title":"Cancers (Basel)"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21388","article-title":"The eighth edition AJCC cancer staging manual: Continuing to build a bridge from a population-based to a more \u201cpersonalized\u201d approach to cancer staging","volume":"67","author":"Amin","year":"2017","journal-title":"CA Cancer J Clin"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1016\/j.drup.2024.101117","article-title":"Circulating tumor cells with increasing aneuploidy predict inferior prognosis and therapeutic resistance in small cell lung cancer","volume":"76","author":"Xie","year":"2024","journal-title":"Drug Resist Update Rev Comm Antimicrob Anticancer Chemother"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2018.08.027","article-title":"Development of pre and post-operative models to predict early recurrence of hepatocellular carcinoma after surgical resection","volume":"69","author":"Chan","year":"2018","journal-title":"J Hepatol"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1097\/SLA.0000000000000747","article-title":"Prognostic nomograms for prediction of recurrence and survival after curative liver resection for hepatocellular carcinoma","volume":"261","author":"Shim","year":"2015","journal-title":"Ann Surg"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0129000","article-title":"Establishment and validation of SSCLIP scoring system to estimate survival in hepatocellular carcinoma patients who received curative liver resection","volume":"10","author":"Huang","year":"2015","journal-title":"PloS One"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2021.11.018","article-title":"BCLC strategy for prognosis prediction and treatment recommendation: The 2022 update","volume":"76","author":"Reig","year":"2022","journal-title":"J Hepatol"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000023339","article-title":"Prognostic value of \u03b3-glutamyl transpeptidase to albumin ratio combined with aspartate aminotransferase to lymphocyte ratio in patients with hepatocellular carcinoma after hepatectomy","volume":"99","author":"Liu","year":"2020","journal-title":"Med (Balt)"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1097\/SLA.0000000000000710","article-title":"Recurrence of hepatocellular cancer after resection: patterns, treatments, and prognosis","volume":"261","author":"Tabrizian","year":"2015","journal-title":"Ann Surg"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1097\/01.sla.0000197706.21803.a1","article-title":"Early and late recurrence after liver resection for hepatocellular carcinoma: prognostic and therapeutic implications","volume":"243","author":"Portolani","year":"2006","journal-title":"Ann Surg"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1186\/s13244-022-01359-5","article-title":"Predictive models and early postoperative recurrence evaluation for hepatocellular carcinoma based on gadoxetic acid-enhanced MR imaging","volume":"14","author":"Li","year":"2023","journal-title":"Insights Imaging"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.2147\/CMAR.S320380","article-title":"Prognostic value of combined CA19\u20139 with aspartate aminotransferase to lymphocyte ratio in patients with intrahepatic cholangiocarcinoma after hepatectomy","volume":"13","author":"Qiu","year":"2021","journal-title":"Cancer Manag Res"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.2147\/OTT.S166614","article-title":"Prognostic role of aspartate aminotransferase-lymphocyte ratio index in patients with metastatic colorectal cancer: results from the randomized ITACa trial","volume":"11","author":"Casadei Gardini","year":"2018","journal-title":"OncoTarg Ther"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1016\/j.hpb.2020.02.002","article-title":"Neutrophil to lymphocyte ratio as a prognostic marker in metastatic gallbladder cancer","volume":"22","author":"Mady","year":"2020","journal-title":"HPB"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1007\/s00330-022-08811-6","article-title":"Comparison of a preoperative MR-based recurrence risk score versus the postoperative score and four clinical staging systems in hepatocellular carcinoma: a retrospective cohort study","volume":"32","author":"Wei","year":"2022","journal-title":"Eur Radiol"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1097\/01.SLA.0000059988.22416.F2","article-title":"Liver resection for hepatocellular carcinoma on cirrhosis: univariate and multivariate analysis of risk factors for intrahepatic recurrence","volume":"237","author":"Ercolani","year":"2003","journal-title":"Ann Surg"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.665497","article-title":"A novel post-operative ALRI model accurately predicts clinical outcomes of resected hepatocellular carcinoma patients","volume":"11","author":"Liao","year":"2021","journal-title":"Front Oncol"},{"key":"B43","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1186\/s12876-025-03949-1","article-title":"The prognostic value of AST-lymphocyte ratio index in liver cancer patients treated with TACE: a systematic review and single-center retrospective study","volume":"25","author":"Tian","year":"2025","journal-title":"BMC Gastroenterol"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.5719","article-title":"Aspartate aminotransferase-lymphocyte ratio index and systemic immune-inflammation index predict overall survival in HBV-related hepatocellular carcinoma patients after transcatheter arterial chemoembolization","volume":"6","author":"Yang","year":"2015","journal-title":"Oncotarget"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.7150\/jca.30663","article-title":"The prognostic value of aspartate aminotransferase to lymphocyte ratio and systemic immune-inflammation index for overall survival of hepatocellular carcinoma patients treated with palliative treatments","volume":"10","author":"Zhao","year":"2019","journal-title":"J Cancer"},{"key":"B46","doi-asserted-by":"publisher","first-page":"694","DOI":"10.6004\/jnccn.2023.0035","article-title":"NCCN Guidelines\u00ae Insights: Biliary tract cancers, Version 2.2023","volume":"21","author":"Benson","year":"2023","journal-title":"J Natl Compr Cancer Netw JNCCN"},{"key":"B47","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1038\/nature17038","article-title":"Metastatic colonization by circulating tumour cells","volume":"529","author":"Massagu\u00e9","year":"2016","journal-title":"Nature"},{"key":"B48","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1038\/s41392-021-00817-8","article-title":"Circulating tumor cells: biology and clinical significance","volume":"6","author":"Lin","year":"2021","journal-title":"Signal Transd Targ Ther"},{"key":"B49","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1186\/s40364-022-00403-2","article-title":"Detection of circulating tumor cells: opportunities and challenges","volume":"10","author":"Ju","year":"2022","journal-title":"biomark Res"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.14218\/JCTH.2024.00230","article-title":"Exploring circulating tumor cells: Detection methods and biomarkers for clinical evaluation in hepatocellular carcinoma","volume":"12","author":"Hsu","year":"2024","journal-title":"J Clin Transl Hepatol"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.3390\/diagnostics15131655","article-title":"Role of liquid biopsy for early detection, prognosis, and therapeutic monitoring of hepatocellular carcinoma","volume":"15","author":"Alrumaihi","year":"2025","journal-title":"Diagn Basel Switz"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.3389\/fnut.2024.1433528","article-title":"Prognostic significance of preoperative prognostic nutritional index in hepatocellular carcinoma after curative hepatectomy: a meta-analysis and systemic review","volume":"11","author":"Zhang","year":"2024","journal-title":"Front Nutr"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.33898","article-title":"Comprehensive clinicopathologic study of alpha fetoprotein-expression in a large cohort of patients with hepatocellular carcinoma","volume":"150","author":"Ridder","year":"2022","journal-title":"Int J Cancer"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1038\/s41416-019-0513-7","article-title":"Molecular portrait of high alpha-fetoprotein in hepatocellular carcinoma: implications for biomarker-driven clinical trials","volume":"121","author":"Montal","year":"2019","journal-title":"Br J Cancer"},{"key":"B55","doi-asserted-by":"publisher","first-page":"4091","DOI":"10.1038\/s41467-021-24386-0","article-title":"Dissecting spatial heterogeneity and the immune-evasion mechanism of CTCs by single-cell RNA-seq in hepatocellular carcinoma","volume":"12","author":"Sun","year":"2021","journal-title":"Nat Commun"},{"key":"B56","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1097\/HEP.0000000000000934","article-title":"Platelet-mediated circulating tumor cell evasion from natural killer cell killing through immune checkpoint CD155-TIGIT","volume":"81","author":"Sun","year":"2025","journal-title":"Hepatol Baltim Md"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1245\/s10434-023-14811-7","article-title":"Perioperative Lymphopenia is Associated with Increased Risk of Recurrence and Worse Survival Following Hepatectomy for Hepatocellular Carcinoma","volume":"31","author":"Tsilimigras","year":"2024","journal-title":"Ann Surg Oncol"}],"container-title":["Frontiers in Oncology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2026.1788776\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,16]],"date-time":"2026-03-16T05:22:49Z","timestamp":1773638569000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2026.1788776\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,16]]},"references-count":57,"alternative-id":["10.3389\/fonc.2026.1788776"],"URL":"https:\/\/doi.org\/10.3389\/fonc.2026.1788776","relation":{},"ISSN":["2234-943X"],"issn-type":[{"value":"2234-943X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,16]]},"article-number":"1788776"}}